During the past decade, The Second Xiangya Hospital of Central South University conducted 227 clinical trials. In the 10-year time frame, 227 clinical trials started and 29 clinical trials were completed, i.e. on average, 12.8% percent of trials that started reached the finish line to date. In the past 5 years, 129 clinical trials started and 24 clinical trials were completed. i.e. 18.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Second Xiangya Hospital of Central South University" #1 sponsor was "Second Xiangya Hospital of Central South University" with 28 trials, followed by "Central South University" with 24 trials sponsored, "Janssen Research & Development, LLC" with 10 trials sponsored, "Pfizer" with 10 trials sponsored and "Eli Lilly and Company" with 10 trials sponsored. Other sponsors include 201 different institutions and companies that sponsored additional 119 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Xiangya Hospital of Central South University" #1 collaborator was "Central South University" with 13 trials as a collaborator, "West China Hospital" with 9 trials as a collaborator, "The First Affiliated Hospital of Zhengzhou University" with 8 trials as a collaborator, "Wuhan Union Hospital, China" with 7 trials as a collaborator and "Xiangya Hospital of Central South University" with 7 trials as a collaborator. Other collaborators include 527 different institutions and companies that were collaborators in the rest 393 trials.

According to Clinical.Site data, the most researched conditions in "The Second Xiangya Hospital of Central South University" are "Schizophrenia" (14 trials), "Chronic Hepatitis B" (9 trials), "Type 1 Diabetes Mellitus" (6 trials), "Non-small Cell Lung Cancer" (5 trials) and "Atopic Dermatitis" (4 trials). Many other conditions were trialed in "The Second Xiangya Hospital of Central South University" in a lesser frequency.

Most popular intervention types in "The Second Xiangya Hospital of Central South University" are "Drug" (198 trials), "Other" (28 trials), "Procedure" (22 trials), "Device" (20 trials) and "Biological" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (55 trials), "placebo" (9 trials), "Insulin" (5 trials), "Ypeginterferon alfa-2b" (5 trials) and "Guselkumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "The Second Xiangya Hospital of Central South University" are 276 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are 106 active trials in "The Second Xiangya Hospital of Central South University". 8 are not yet recruiting, 76 are recruiting, 20 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 105 completed trials in The Second Xiangya Hospital of Central South University, 3 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in The Second Xiangya Hospital of Central South University, 14 "Phase 1" clinical trials were conducted, 68 "Phase 2" clinical trials and 101 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 36 trials, and there were also 47 trials that are defined as “Not Applicable".